Oslo, Norway, April 28, 2023
The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2022. Please find the report attached, as well as the report according to the European Single Electronic Format (ESEF). The Annual Report 2022 is also available on the company's website www.pcibiotech.com.
For further information, please contact:
PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo
Ronny Skuggedal, CEO, rs@pcibiotech.no, Mobile: +47 940 05 757
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Attachments
- 2022 Annual report PCI Biotech Holding ASA (https://ml-eu.globenewswire.com/Resource/Download/4764bd1b-88e1-490b-b58d-838bcae307bf)
- pcibiotechholdingasa_2022_12_31_en (https://ml-eu.globenewswire.com/Resource/Download/e958fc79-7e2b-4f04-9ce6-5fe390064600)
